Ftse Mib
37.582,05
0,00%
DAX
22.037,83
0,48%
S&P 500
6.068,50
0,03%
NASDAQ
19.643,86
-0,36%
Bitcoin
96.099,59
0,36%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ TELA Bio Inc (TELA) TELA Bio Inc (TELA) Notizie

TELA

TELA Bio (TELA)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TELA
DataOraFonteTitoloSimboloCompagnia
24/01/202522:05GlobeNewswire Inc.TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TELATELA Bio Inc
19/11/202422:05GlobeNewswire Inc.TELA Bio to Participate in Piper Sandler’s 36th Annual Healthcare ConferenceNASDAQ:TELATELA Bio Inc
07/11/202422:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TELATELA Bio Inc
07/11/202422:05GlobeNewswire Inc.TELA Bio Reports Third Quarter 2024 Financial ResultsNASDAQ:TELATELA Bio Inc
28/10/202421:06Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:TELATELA Bio Inc
24/10/202422:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TELATELA Bio Inc
24/10/202422:05GlobeNewswire Inc.TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional SharesNASDAQ:TELATELA Bio Inc
23/10/202423:15Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TELATELA Bio Inc
23/10/202414:07GlobeNewswire Inc.TELA Bio Announces Pricing of Public Offering of Common Stock and Pre-Funded WarrantsNASDAQ:TELATELA Bio Inc
22/10/202422:05GlobeNewswire Inc.TELA Bio Announces Proposed Public Offering of Common Stock and Pre-Funded WarrantsNASDAQ:TELATELA Bio Inc
17/10/202422:05GlobeNewswire Inc.TELA Bio to Announce Third Quarter 2024 Financial ResultsNASDAQ:TELATELA Bio Inc
13/08/202422:20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TELATELA Bio Inc
12/08/202422:05GlobeNewswire Inc.TELA Bio Reports Second Quarter 2024 Financial Results and Reiterates Full Year 2024 Revenue GuidanceNASDAQ:TELATELA Bio Inc
30/07/202423:50Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:TELATELA Bio Inc
25/07/202422:05GlobeNewswire Inc.TELA Bio to Participate in the Canaccord Genuity 44th Annual Growth ConferenceNASDAQ:TELATELA Bio Inc
22/07/202422:05GlobeNewswire Inc.TELA Bio to Announce Second Quarter 2024 Financial ResultsNASDAQ:TELATELA Bio Inc
10/06/202415:00Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TELATELA Bio Inc
06/06/202422:55Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TELATELA Bio Inc
04/06/202422:05GlobeNewswire Inc.TELA Bio Appoints Jeffrey Blizard to its Board of DirectorsNASDAQ:TELATELA Bio Inc
20/05/202422:03GlobeNewswire Inc.TELA Bio Appoints Greg Firestone as Chief Commercial OfficerNASDAQ:TELATELA Bio Inc
09/05/202422:05GlobeNewswire Inc.TELA Bio Reports First Quarter 2024 Financial ResultsNASDAQ:TELATELA Bio Inc
25/04/202413:00GlobeNewswire Inc.TELA Bio to Announce First Quarter 2024 Financial ResultsNASDAQ:TELATELA Bio Inc
15/04/202413:00GlobeNewswire Inc.TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia ProceduresNASDAQ:TELATELA Bio Inc
08/04/202413:00GlobeNewswire Inc.TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon StrategyNASDAQ:TELATELA Bio Inc
21/03/202421:05GlobeNewswire Inc.TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial ResultsNASDAQ:TELATELA Bio Inc
21/03/202412:00GlobeNewswire Inc.TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia SurgeryNASDAQ:TELATELA Bio Inc
20/03/202412:00GlobeNewswire Inc.TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDXNASDAQ:TELATELA Bio Inc
20/03/202412:00GlobeNewswire Inc.MIMEDX Expands Portfolio with Fibrillar Collagen Wound DressingNASDAQ:TELATELA Bio Inc
29/02/202413:00GlobeNewswire Inc.TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:TELATELA Bio Inc
16/02/202422:05Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:TELATELA Bio Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TELA

La tua Cronologia

LSE
67SQ
Anz Bank 50
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci